• Mashup Score: 0

    In this latest episode of ASTCT Talks, we sit down with Associate Professor Nada Hamad, senior staff specialist in bone marrow transplant, and a clinical and laboratory hematologist at St. Vincent’s hospital in Sydney, to explore the impact of intersectionality on graft-versus-host disease (GVHD) in transplant recipients. She dives into how gender and race can compound biases in research, education, and clinical practice, affecting GVHD severity and outcomes. Further discussions center on the need for research into how age, socioeconomic status, and geographic region intersect with GVHD incidence and treatment strategies. In addition, Nada stresses the need to include social determinants of health in prognostic models to improve patient outcomes. She also advocates for healthcare professionals to create safe spaces and co-design solutions that integrate intersectionality into healthcare practices for patients with intersecting identities.

    Tweet Tweets with this article
    • Thank you @ASTCT for amplifying the topic of #IntersectionalMed in #TCT and #GVHD 🙏 @ASH_hematology @ANZTCT1 @hsanz_org_au @ALLGtrials @TheEBMT Listen to "Navigating Intersectionality in GVHD and Transplant Medicine" by ASTCT Talks https://t.co/CIkReQd3KO

  • Mashup Score: 2

    The ANZTCT’s Inaugural Annual Scientific Meeting (ASM) is a multi-disciplinary transplant and cellular therapies (TCT) event. The ANZTCT ASM will be held across three days from Thursday 7 – Saturday 9 September 2023 at the Manly Pacific Hotel, on the land of the Guringai people, in Sydney’s beautiful Northern Beaches. The comprehensive program of sessions covering TCT…

    Tweet Tweets with this article
    • I am so proud to present the innaugural Australia and New Zealand Transplant and Cellular Therapies Annual Scientific Meeting @ANZTCT1 partnering with Arrow Foundation and ABDMR 7-9th Sep 2023 in Sydney: https://t.co/aY6DZHm8jw @abmtrr_stats @ASTCT @TheEBMT @hsanz_org_au… https://t.co/Dx3C5PwSk4 https://t.co/NSElTZf492